Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8623178 | 1.00 | CA12 (0.39) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL7676364 | 0.89 | CA12 (0.36) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL13288334 | 0.88 | CA12 (0.35) | CA12CA1CA2CA9 | |
| SCHEMBL30892508 | 0.82 | ABCC1 (0.40) | CA12CA1CA2CA9ABCC1 | |
| SCHEMBL29657965 | 0.79 | CA12 (0.35) | CA12CA1CA2CA9 | |
| SCHEMBL2890927 | 0.73 | CA12 (0.55) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL29088214 | 0.71 | CA12 (0.53) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL29005813 | 0.70 | KMT2A (0.42) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL29164396 | 0.70 | — | — | |
| SCHEMBL19004240 | 0.65 | CA12 (0.37) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6388087-B1 | ROCKET PROPELLANTS, EXPLOSIVES | FLUOROCHEM INC. | 2002-05-14 | — | — | US | claimed |
| US-5747729-A | SOLID PROPELLANT COMPRISING BINDER, ENERGETIC FILLER COMPRISING DINITRATED BIFURAZANE DERIVATIVE | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1998-05-05 | — | — | US | claimed |
| CN-120665030-A | 3,3 '-Diazidoethoxy-4, 4' -azofurazan compound and preparation method and application thereof | 西安近代化学研究所 | 2025-09-19 | — | — | CN | disclosed |
| CN-119192166-A | Furazan hydrazone energetic compound and synthesis method thereof | 南京理工大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-117800797-A | Hydroxylamine nitrate monocomponent propellant and preparation method thereof | 中国航天科技创新研究院 | 2024-04-02 | — | — | CN | disclosed |
| CN-110890135-B | Prediction method of energetic N-oxide crystal structure | 西安近代化学研究所 | 2022-05-24 | — | — | CN | disclosed |
| US-8211252-B2 | Furazane derivatives, preparation thereof and energetic compositions containing them | EURENCO (FR) | 2012-07-03 | — | — | US | disclosed |
| US-20100132856-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2010-06-03 | — | — | US | disclosed |
| EP-2125796-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE Matériaux Energétiques (FR) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008102092-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2008-08-28 | — | — | WO | disclosed |
| US-6388087-B1 | ROCKET PROPELLANTS, EXPLOSIVES | FLUOROCHEM INC. | 2002-05-14 | — | — | US | disclosed |
| US-6388087-B1 | ROCKET PROPELLANTS, EXPLOSIVES | FLUOROCHEM INC. | 2002-05-14 | — | — | US | disclosed |
| US-5747729-A | SOLID PROPELLANT COMPRISING BINDER, ENERGETIC FILLER COMPRISING DINITRATED BIFURAZANE DERIVATIVE | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1998-05-05 | — | — | US | disclosed |
| US-5747729-A | SOLID PROPELLANT COMPRISING BINDER, ENERGETIC FILLER COMPRISING DINITRATED BIFURAZANE DERIVATIVE | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1998-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132856-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | NOX5, COX5A, TXN2 | CA12 4413/4885CA1 1875/4885CA2 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.